Advertisement
Home Tags Cancer: Bladder

Tag: Cancer: Bladder

Survival Up With Enfortumab Vedotin + Pembrolizumab in Urothelial Cancer

Significantly longer progression-free and overall survival seen in patients with previously untreated locally advanced or metastatic urothelial carcinoma

Erdafitinib Improves Survival in Metastatic Urothelial Cancer With FGFR Mutation

Longer median overall survival and progression-free survival seen with erdafitinib versus chemotherapy

Selenium Not Linked to Recurrence of Non-Muscle-Invasive Bladder Cancer

Vitamin E supplementation is associated with increased risk for recurrence; neither influenced progression, overall survival

Gemcitabine, Cisplatin, Nivolumab Facilitate Bladder Sparing

Clinical complete response of 43 percent seen for those with muscle-invasive bladder cancer receiving neoadjuvant gemcitabine, cisplatin, plus nivolumab

Urine-Based DNA Methylation Test Can Detect Bladder Cancer

PENK methylation test has high sensitivity and specificity for detecting bladder cancer in patients with hematuria

Exposure to Agent Orange Linked to Risk of Bladder Cancer

Small, but significantly increased, risk for male Vietnam vets; increased risk seen among veterans younger than the median age

Bladder Cancer Treatment May Lower Risk for Alzheimer and Related Dementias

Greater effect seen for patients aged 70 years and older at time of bacillus Calmette-Guerin vaccination

ASCO: Extended Lymph Node Removal Not Beneficial for Bladder Cancer

No benefit in terms of disease-free or overall survival seen for those with muscle-invasive bladder cancer undergoing radical cystectomy

AUA: Genomic Urine Test Accurately Predicts Bladder Cancer

Findings based on a subset of 10 genes with greatest predictive power

Urothelial Cancer Prediction Model Has High Sensitivity, Specificity

Model, which considers 10 genes from UroAmp uCGP test, had high sensitivity and specificity in two validation cohorts